Today’s health care environment is marked by transition and uncertainty. Health care managers must regularly juggle multiple project initiatives with limited time and resources, which often means ...

The Japanese pharmaceutical company, which had made cell therapy a priority a few years ago, aims to partner its work while prioritizing investments elsewhere.

Takeda will step away from cell therapy in favour of biologics, small molecules and ADCs in a “strategic portfolio ...

Japan’s largest drugmaker Takeda today revealed that, as part of a strategic portfolio prioritization process, it has made ...

Prioritizing metastatic non-small cell lung cancer launch and focusing research and development activities in areas of greatest anticipated value creation Expected reduction in residual operating ...

Takeda (TAK) announced that as part of a strategic portfolio prioritization process, the company has made the decision to discontinue its cell ...

Takeda Pharmaceutical Co has decided to discontinue its cell therapy research as part of a strategic portfolio prioritization process. The company plans to seek an external partner to advance its cell ...

Takeda shifts focus from cell therapy to innovative drug candidates, aiming for transformative therapies and strategic ...

Requirements prioritization is an essential process in software development that involves identifying, ranking and selecting the requirements to be implemented in a project. Given the limited ...

Akari’s PAS-nomacopan is a bispecific complement and leukotriene B4 inhibitor with prolonged duration of action being developed for GA. “As part of the merger process, the boards of each company ...

Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results Annual cash burn will be reduced to approximately $50 million from approximately $80 ...

ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced a series of actions to strengthen and optimize business operations to support near-term growth drivers and long-term value ...